Pierre-Francois Cartron

Title: Pierre-Francois Cartron: Innovator in Cancer Prognosis

Introduction

Pierre-Francois Cartron is a notable inventor based in Nantes, France. He has made significant contributions to the field of cancer research, particularly in developing methods for prognosis and treatment. With a total of 2 patents, his work is recognized for its potential impact on patient care.

Latest Patents

One of Pierre-Francois Cartron's latest patents involves a method for treating and prognosing cancer. This invention outlines an in vitro method to determine the prognosis of survival time for cancer patients. The process includes determining the expression level of the couple DNMT3A/ISGF3γ in a patient sample, comparing this level with a predetermined reference value, and providing prognostic outcomes based on the results. A lower expression level indicates a good prognosis, while a higher level suggests a poor prognosis. Additionally, the invention includes compounds that act as DNMT3A/ISGF3γ antagonists or gene expression inhibitors for cancer treatment and prevention.

Career Highlights

Pierre-Francois Cartron has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Université d'Angers. His experience in these organizations has contributed to his expertise in medical research and innovation.

Collaborations

Throughout his career, Pierre-Francois Cartron has collaborated with professionals like Mathilde Cheray and Francois Valette. These partnerships have likely enhanced his research and development efforts in the field of cancer prognosis.

Conclusion

Pierre-Francois Cartron's innovative work in cancer prognosis and treatment showcases his dedication to improving patient outcomes. His contributions through patents and collaborations highlight the importance of research in advancing medical science.